Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
Clinical trial NCT03046251 · COMPLETED
Trial details
- NCT number
- NCT03046251
- Sponsor
- State University of New York at Buffalo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.